Novel approach could limit common complications of immunotherapy

(University of Chicago Medical Center) Connecting cancer immunotherapy drugs such as anti-CTLA4 and anti-PD-L1 to peptides that bind to tissues in and around tumors enhanced their effects while limiting adverse events.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news